Vimarsana
Biggest News Aggregation in the World

Everest 1 Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Everest 1 Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Everest 1 Study Today - Breaking & Trending Today

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors - Vimarsana News

Simeone and Fakih Detail Research Objectives With A2B530 in CEA-Expressing Solid Tumors

Published: December 19, 2023

Drs Simeone and Fakih discuss the main objective and design of the observational BASECAMP-1 study and how it functions alongside the EVEREST-1 study, which is evaluating the autologous CAR T-cell therapy A2B530 in patients with CEA-expressing solid tumors that have lost HLA-A*02 expression.

Source: onclive.com
Related Topics:
United StatesNew YorkMarwang FakihJudy Bernard BriskinDianem SimeoneKyle DohertyGastrointestinal Gi Cancer ProgramGrossman School Of MedicineJudy Bernard Briskin CenterPerlmutter Cancer CenterTranslational ResearchClinical Research At City Of HopePancreatic Cancer CenterClinical ResearchDepartment Of SurgeryDepartment Of PathologyDepartment Of Medical Oncology Therapeutics ResearchLive On AirIsaac Perlmutter ProfessorBernard Briskin Distinguished DirectorMedical OncologyTherapeutics ResearchCancer ProgramBernard Briskin CenterOnclive On Air
BASECAMP-1 Trial Selects Patients With Solid Tumors for Future Treatment With Novel CAR T-Cell Therapy - Vimarsana News

BASECAMP-1 Trial Selects Patients With Solid Tumors for Future Treatment With Novel CAR T-Cell Therapy

Published: September 14, 2023

J. Randolph Hecht, MD,

Source: onclive.com
Related Topics:
United StatesLos AngelesJ Randolph HechtDavid Geffen School Of MedicineGastrointestinal Oncology ProgramT Cell TmodOncology ProgramClinical MedicineDavid Geffen SchoolNorth AmericaBasecamp 1 StudyEverest 1 StudyCart Cell Therapy A2b530Patients With Solid Tumors